Target intelligence / Profile preview

Ribosomal protein L10 pseudogene 16 (RPL10P16)

Target
RPL10P16
Molecular classification
Other (Pseudogene), Ribosomal protein-related pseudogene
01

Overview

Ribosomal protein L10 pseudogene 16 (RPL10P16) is one of many ribosomal protein pseudogenes found in the human genome[1][4]. These pseudogenes arose through retrotransposition events, where copies of mRNA from protein-coding genes were integrated back into the genome, losing their protein-coding potential. RPL10P16 shares high sequence similarity with the functional RPL10 gene but typically contains genetic disablements (such as stop codons, frameshift mutations, or truncations) that prevent it from encoding a functional protein. Pseudogenes like RPL10P16 do not produce proteins and are not considered therapeutic targets, receptors, enzymes, or transporters. They are useful in genomic studies for understanding genome evolution but have no recognized role in drug interactions, disease, or as biomarkers[4]. In summary, this entity is a non-functional pseudogene and not appropriate as a drug target.

Other names
RPL10_6_1628RPL10P16
02

Biological functions

Other (No functional protein produced; does not participate in biological processes as a protein)
03

Disease associations

Other (No direct involvement in disease attributed to this pseudogene; its parent gene, RPL10, is involved in ribosome function and some ribosomopathies, but RPL10P16 itself is not)

Beyond the preview

Go deeper on Ribosomal protein L10 pseudogene 16 (RPL10P16).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L10 pseudogene 16 (RPL10P16).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call